Prostate Carcinoma — Trials

Prostate Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,176 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 230
Ph III recruiting: 20
Growth YoY: −2.6%
Industry share: 25%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (184)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04134208	An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer	terminated	Phase 4	2	M.D. Anderson Cancer CenterOTHER	1	Jan 16, 2025	clinicaltrials
NCT02441517	A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment	terminated	Phase 4	4	Astellas Pharma Global Development, Inc.INDUSTRY	1	Apr 19, 2018